Ligand Pharmaceuticals Incorporated / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €332.87M +13.9% €125.96M +14.9% 37.8% +0.0031 pp N/A N/A
    (estimated) €292.13M +13.6% €109.63M +8.2% 37.5% -0.019 pp N/A N/A
    (estimated) €257.09M +22.6% €101.33M +36.2% 39.4% +0.039 pp N/A N/A
    (estimated) €209.63M +15.2% €74.38M -2,291.0% 35.5% +0.37 pp N/A N/A
    (estimated) €182.01M +27.7% -€3.39M -143.9% -1.9% -0.073 pp N/A N/A
    €142.56M +27.3% €7.73M -82.6% 5.4% -0.34 pp €84.33M -3.5% 59.2% -0.19 pp
    €112.00M -33.1% €44.48M -256.3% 39.7% +0.57 pp €87.41M -34.2% 78.0% -0.013 pp
    €167.39M -18.8% -€28.46M -158.4% -17.0% -0.41 pp €132.87M +77.9% 79.4% +0.43 pp
    €206.03M +29.6% €48.74M -2,014.2% 23.7% +0.25 pp €74.68M +48.3% 36.2% +0.046 pp
    €159.01M +55.0% -€2.55M -100.5% -1.6% -5.2 pp €50.36M -320.5% 31.7% +0.54 pp
    €102.59M -52.2% €536.76M +339.1% 523.2% +4.7 pp -€22.84M -113.1% -22.3% -1.0 pp
    €214.48M +78.2% €122.25M +1,041.5% 57.0% +0.48 pp €174.81M +114.1% 81.5% +0.14 pp
    €120.35M +29.5% €10.71M -630.5% 8.9% +0.11 pp €81.65M +16.0% 67.8% -0.079 pp
    €92.95M +51.5% -€2.02M -101.0% -2.2% -3.2 pp €70.41M +85.1% 75.7% +0.14 pp
    €61.34M €196.03M 319.6% €38.03M 62.0%

    Notifications